Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Relmada’s Phase III Depression Study Scuppered By ‘Placebo Paradox’
Adjunctive Studies Will Continue
Oct 14 2022
•
By
Andrew McConaghie
After years of no new therapies, major depressive disorder is seeing advances again. • Source: Shutterstock
More from Neurological
More from Therapy Areas